1. RADEKOR: Speciation and Transfer of Radionuclides (RN) in the Human Organism Especially Taking into Account Decorporation Agents (DA) – a Joint Project, Part II
- Author
-
Heller, A., Senwitz, C., Acker, M., Taut, S., (0000-0002-4505-3865) Stumpf, T., (0000-0003-3241-3443) Barkleit, A., Heller, A., Senwitz, C., Acker, M., Taut, S., (0000-0002-4505-3865) Stumpf, T., and (0000-0003-3241-3443) Barkleit, A.
- Abstract
When radionuclides (RN) enter the food chain and are ingested by humans, they pose a potential health risk due to their radio- and chemotoxicity. To minimize the health risk, decorporation agents (DA), which are usually strong complexants, are used after the accidental incorporation of RN to increase their excretion. In order to accurately assess the health risk after oral ingestion and to apply effective decontamination methods, it is essential to understand the processes of (bio)chemistry and speciation of RN at the molecular and cellular level. Within the joint research project RADEKOR: “Speciation and transfer of radionuclides in the human organism especially taking into account decorporation agents”, molecular speciation studies of RN in artificial biofluids of the digestive system of humans and cytotoxicity studies with respective human and rat renal cell lines in vitro both in the absence and presence of DA were performed. As DA we investigated i) aminopolycarboxylate diethylenetriaminepentaacetic acid DTPA as the only approved and commercially used DA and ii) some promising new chelators like the hydroxypyridinone 3,4,3-(LI-1,2-HOPO) (HOPO) and 1-hydroxy-ethylidene-1,1-diphosphonic acid (HEDP), which was formerly used as a pharmaceutical. First, the complex formation of the non-radioactive An(III) analogue Eu(III) with HEDP in aqueous solution and cell culture medium was studied. Second, Eu(III) and Am(III) cytotoxicity onto kidney cells was investigated in absence and presence of DTPA and HOPO. Finally, the molecular speciation of Eu(III) and Am/Cm(III) with and w/o DTPA and HOPO was studied in both cell culture medium and exposed renal cells. The results of this work contribute to a better understanding of the effect of DA after RN incorporation at the molecular level and support making them more effective in the future.
- Published
- 2024